Rennova Health Inc (OTCQB:RNVA)

Delayed Data
As of Feb 16
 -0.0016 / -18.44%
Today’s Change
Today|||52-Week Range
Electronic Technology
Electronic Production Equipment

Company Description

Rennova Health, Inc. engages in provision of diagnostics and supportive software solutions to healthcare providers. It operates through the following segments: Clinical Laboratory Operations; Supportive Software Solutions; and Decision Support Informatics. The Clinical Laboratory Operations segment provides urine drug toxicology testing to physicians, clinics, and rehabilitation facilities. The Supportive Software Solutions segment offers a customizable Electronic Health Record (EHR) and revenue cycle management services providing a full suite of billing services to substance abuse and behavioral health providers, as well as a dictation-based ambulatory EHR for physician practices and advanced transcription services. The Decision Support and Informatics segment develops and markets medical information and clinical decision support products and services intended to set a standard for the clinical interpretation of genomics-based, precision medicine. The company was founded in December 1989 and is headquartered in West Palm Beach, FL.

Contact Information

Rennova Health, Inc.
400 South Australian Avenue
West Palm Beach Florida 33401
P:(561) 855-1626
Investor Relations:
(156) 166-6818



Other institutional10.44%
Mutual fund holders0.02%
Individual stakeholders--

Top Executives

Seamus LaganPresident, Chief Executive Officer & Director
Sebastien SainsburyHead-Investment Development & Public Relations
Karen TaylorDirector-Human Resources
Victoria NemersonGeneral Counsel